Drug Type Small molecule drug |
Synonyms BMS 351, BMS-351, BMS351 |
Target |
Action inhibitors |
Mechanism CYP17A1 inhibitors(Steroid 17-alpha-hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H12F3N3 |
InChIKeyOFFVLUDFSIUVMI-UHFFFAOYSA-N |
CAS Registry1370001-71-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Discovery | United States | 02 Dec 2015 |